Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...
There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...
First-line treatment with pulsed field ablation (PFA) reduced the risk of recurrence of atrial arrhythmia among patients with persistent atrial fibrillation (Afib), the randomized AVANT GUARD trial ...
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...
Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing ...
Key findings from the trial: PFA achieved superiority over AADs with a primary effectiveness rate of 56.0% at 12 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results